←
PV Reporter787 posts
PV Reporter avatar

PV Reporter

@PVReporter

PV Reporter provides tools for MPN research. David Wallace - Founder, Fierce PV patient & advocate. CEO of non-profit MPNCancerConnection.org

◷ Joined September 2013▧ 223 Photos and videos
PV Reporter avatar
PV Reporter@PVReporter·Oct 19

🚨 BIG MPN NEWS! Merck KGaA agrees to acquire Silence Therapeutics for $1.3 BILLION. At the center: divesiran, an investigational PV therapy with promising Phase 2 results. Another major investment in the future of MPN treatment! #PolycythemiaVera #BloodCancer

Post attachment
PV Reporter avatar
PV Reporter@PVReporter·Oct 14

🧊 MPNs are more than blood counts. Beneath the surface: fatigue, brain fog, itching, bone pain, night sweats, headaches & emotional challenges. Living with PV, ET or MF can mean struggles others never see. What's your biggest invisible symptom? PVReporter.com

Post attachment
PV Reporter avatar
PV Reporter@PVReporter·Sep 25

I live with PV. I know the hematocrit number matters, and the person behind it does, too. 🎯 Below 45% is the established target. Symptoms still deserve attention. Patients, caregivers, physicians, and researchers: let’s talk. pvreporter.com/polycythemia-…

PV Reporter avatar
PV Reporter@PVReporter·Sep 13

BESREMi is now FDA approved for adults with #essentialthrombocythemia (ET). What should patients know? My PV Reporter article covers trial results, dosing, safety, and questions for your hematologist. pvreporter.com/fda-approves-… #bloodcancerawarenessmonth #BESREMi #pvreporter

PV Reporter avatar
PV Reporter@PVReporter·Sep 9

September is #BloodCancerAwarenessMonth. Ahead of #MPNAwarenessDay tomorrow, check out our free Guide to Polycythemia Vera: mpncancerconnection.org/2026… Thank you to our generous supporters, @PharmaEssentia, @Incyte & @TakedaPharma, for making this resource possible.

PV Reporter avatar
PV Reporter@PVReporter·Sep 3

Honored that Hemostasis Today featured my PV Reporter article on the FDA approval of MIMRYLO™ (rusfertide) for adults with PV. Grateful to see patient-focused MPN reporting reach a wider audience. 🙏 hemostasistoday.com/voices/d… #PolycythemiaVera #MPN #BloodCancerAwarenessMonth

PV Reporter avatar
PV Reporter@PVReporter·Sep 2

A new chapter in #PolycythemiaVera treatment begins. The FDA has approved MIMRYLO™ (rusfertide), the first hepcidin mimetic for erythrocytosis in adults with PV. What patients should know: pvreporter.com/fda-approves-… #BloodCancerAwarenessMonth #Mimrylo

PV Reporter avatar
PV Reporter@PVReporter·May 2

🚨 BREAKING: FDA approves Jakafi XR, a once-daily ruxolitinib tablet for MF, PV & GVHD patients. Same proven treatment, simpler schedule. Available May 8. Big win for our community. #pvreporter #myelofibrosis #polycythemiavera pvreporter.com/one-pill-once…

PV Reporter avatar
PV Reporter@PVReporter·Apr 20

He introduced interferon for MPNs. Helped launch Gleevec. Developed the bone marrow biopsy used worldwide. Dr. Richard T. Silver passed away April 17, 2026. Age 97. Our community owes him so much. 🙏 🔗 pvreporter.com/dr-richard-si… #MPNcommunity #BloodCancer #PolycythemiaVera

PV Reporter avatar
PV Reporter@PVReporter·10 Oct 2025

🧬New on PV Reporter: Interferon Treatment for MPNs Learn how interferon works, benefits for PV, ET, and MF patients, side effects, and key questions to ask your doctor. 🔗 Learn more: pvreporter.com/interferon-tr…